What are the side effects of oral GLP-1 medicines
Dipeptidyl peptidase 4 (DPP-4) inhibitors inhibit DPP-4, which is a ubiquitous enzyme expressed on the surface of most cell types that deactivates GLP-1
Research shows that a notable proportion of weight lost during GLP-1 treatment can come from lean body mass rather than fat alone - depending on the medication, individual factors, and whether resistance training was maintained during treatment
Anthem Medicare Advantage plans follow CMS guidelines on GLP-1 coverage, with limited flexibility to add benefits beyond what traditional Medicare covers
In the case of children it can have a profound impact on their school performance, with many facing bullying and discrimination
Cargo holds can reach temperatures below freezing, which damages semaglutide just as surely as heat does